Vertex Pharmaceuticals Inc (VRTX)
450.97
+0.60
(+0.13%)
USD |
NASDAQ |
Nov 22, 16:00
451.02
+0.05
(+0.01%)
Pre-Market: 20:00
Vertex Pharmaceuticals Price: 450.97 for Nov. 22, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 22, 2024 | 454.30 | 457.54 | 449.04 | 450.97 | 1.265M |
| Nov 21, 2024 | 454.24 | 455.43 | 445.00 | 450.37 | 1.508M |
| Nov 20, 2024 | 448.46 | 451.76 | 445.38 | 451.23 | 1.651M |
| Nov 19, 2024 | 462.80 | 463.90 | 447.14 | 448.01 | 2.193M |
| Nov 18, 2024 | 465.19 | 468.88 | 458.05 | 467.01 | 1.129M |
| Nov 15, 2024 | 478.56 | 479.94 | 458.10 | 465.70 | 2.581M |
| Nov 14, 2024 | 495.62 | 496.33 | 483.55 | 483.96 | 1.232M |
| Nov 13, 2024 | 491.34 | 498.25 | 491.03 | 494.61 | 1.079M |
| Nov 12, 2024 | 503.00 | 508.04 | 489.02 | 490.00 | 1.365M |
| Nov 11, 2024 | 518.27 | 518.35 | 500.13 | 501.72 | 1.336M |
| Nov 08, 2024 | 507.17 | 519.88 | 504.94 | 516.74 | 1.260M |
| Nov 07, 2024 | 493.70 | 504.31 | 486.64 | 502.45 | 992325.0 |
| Nov 06, 2024 | 505.35 | 506.65 | 485.29 | 493.64 | 1.649M |
| Nov 05, 2024 | 483.00 | 503.20 | 474.00 | 499.88 | 1.723M |
| Nov 04, 2024 | 473.91 | 475.48 | 468.77 | 472.80 | 1.248M |
| Nov 01, 2024 | 471.06 | 475.73 | 463.14 | 471.12 | 1.353M |
| Oct 31, 2024 | 471.58 | 477.70 | 468.98 | 475.98 | 1.376M |
| Oct 30, 2024 | 470.44 | 475.46 | 468.47 | 475.08 | 721967.0 |
| Oct 29, 2024 | 476.33 | 478.06 | 469.62 | 470.36 | 999658.0 |
| Oct 28, 2024 | 477.95 | 478.32 | 474.68 | 476.37 | 501452.0 |
| Oct 25, 2024 | 477.20 | 480.41 | 475.05 | 477.70 | 1.020M |
| Oct 24, 2024 | 473.35 | 477.84 | 471.87 | 471.91 | 674034.0 |
| Oct 23, 2024 | 474.47 | 477.47 | 464.78 | 470.05 | 991373.0 |
| Oct 22, 2024 | 479.43 | 482.87 | 473.58 | 474.91 | 1.133M |
| Oct 21, 2024 | 480.17 | 487.88 | 477.66 | 478.09 | 689638.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
177.01
Minimum
Oct 05 2021
516.74
Maximum
Nov 08 2024
299.53
Average
282.76
Median
Price Benchmarks
| Eli Lilly and Co | 748.01 |
| Gilead Sciences Inc | 90.19 |
| Bristol-Myers Squibb Co | 58.87 |
| Moderna Inc | 41.11 |
| Pfizer Inc | 25.65 |
Price Related Metrics
| PS Ratio | 11.05 |
| Price to Book Value | 7.43 |
| Earnings Yield | -0.44% |
| Market Cap | 116.14B |
| Operating PE Ratio | 27.69 |
| Normalized PE Ratio | 38.13 |